Factors influencing the generation of murine dendritic cells from bone marrow: The special role of fetal calf serum

Immunobiology

Volumn 212, Issue 9-10, 2008, Pages 855-862

  Lutz, Manfred B ^a   Rößner, Susanne ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Culture conditions; Dendritic cells; Fetal calf serum

Indexed keywords

CD135 ANTIGEN; CD34 ANTIGEN; DENDRITIC CELL VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AUTOIMMUNE DISEASE; BONE MARROW CELL; BONE MARROW CULTURE; CELL CULTURE; CELL DENSITY; CELL ISOLATION; CELL MATURATION; CELL SUBPOPULATION; CULTURE MEDIUM; DENDRITIC CELL; FETAL CALF SERUM; HUMAN; MAST CELL; MONOCYTE; MOUSE STRAIN; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; STRAIN DIFFERENCE;

EID: 37049031915     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2007.09.001     Document Type: Review

References (39)

1. Austyn J.M. Dendritic cells. Curr. Opin. Hematol. 5 (1998) 3-15
2. Bai L., Feuerer M., Beckhove P., Umansky V., and Schirrmacher V. Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells. Int. J. Oncol. 20 (2002) 247-253
3. Baumeister T., Rossner S., Pech G., de Bruijn M.F., Leenen P.J., Schuler G., and Lutz M.B. Interleukin-3Ralpha+ myeloid dendritic cells and mast cells develop simultaneously from different bone marrow precursors in cultures with interleukin-3. J. Invest. Dermatol. 121 (2003) 280-288
4. Bowers W.E.a.B. Differentiation of dendritic cells in cultures of rat bone marrow cells. J. Exp. Med. 163 (1986) 872-883
5. Brand U., Bellinghausen I., Enk A.H., Jonuleit H., Becker D., Knop J., and Saloga J. Influence of extracellular matrix proteins on the development of cultured human dendritic cells. Eur. J. Immunol. 28 (1998) 1673-1680
6. Caux C., Durand I., Moreau I., Duvert V., Saeland S., and Banchereau J. Tumor necrosis factor alpha cooperates with interleukin 3 in the recruitment of a primitive subset of human CD34+ progenitors. J. Exp. Med. 177 (1993) 1815-1820
7. Daro E., Pulendran B., Brasel K., Teepe M., Pettit D., Lynch D.H., Vremec D., Robb L., Shortman K., McKenna H.J., Maliszewski C.R., and Maraskovsky E. Polyethylene glycol-modified GM-CSF expands CD11bhighCD11chigh but not CD11blowCD11chigh murine dendritic cells In vivo: a comparative analysis with flt3 ligand. J. Immunol. 165 (2000) 49-58
8. Feili-Hariri M., and Morel P.A. Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes-prone strains. Clin. Immunol. 98 (2001) 133-142
9. Haase C., Ejrnaes M., Juedes A.E., Wolfe T., Markholst H., and von Herrath M.G. Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo. Blood 106 (2005) 4225-4233
10. Inaba K., Inaba M., Romani N., Aya H., Deguchi M., Ikehara S., Muramatsu S., and Steinman R.M. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176 (1992) 1693-1702
11. Lu L., Hsieh M., Oriss T.B., Morel P.A., Starzl T.E., Rao A.S., and Thomson A.W. Generation of DC from mouse spleen cell cultures in response to GM-CSF: immunophenotypic and functional analyses. Immunology 84 (1995) 127-134
12. Lutz M.B. IL-3 in dendritic cell development and function. A comparison with GM-CSF and IL-4. Immunobiology 209 (2004) 79-87
13. Lutz M.B., Kukutsch N., Ogilvie A.L., Rößner S., Koch F., Romani N., and Schuler G. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J. Immunol. Methods 223 (1999) 77-92
14. Lutz M.B., Kukutsch N.A., Menges M., Rößner S., and Schuler G. Culture of bone marrow cells in GM-CSF plus high doses of lipopolysaccharide generates exclusively immature dendritic cells which induce alloantigen-specific CD4 T cell anergy in vitro. Eur. J. Immunol. 30 (2000) 1048-1052
15. Lutz M.B., Suri R.M., Niimi M., Ogilvie A.L.J., Kukutsch N.A., Rößner S., Schuler G., and Austyn J.M. Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation-resistant and prolong allograft survival in vivo. Eur. J. Immunol. 30 (2000) 1813-1822
16. Lutz M.B., Schnarre M., Rößner S., Röllinghoff M., Schuler G., and Gessner A. Differential functions of IL-4R type I and II for dendritic cell maturation and IL-12 production. J. Immunol. 169 (2002) 3574-3580
17. Maraskovsky E., Brasel K., Teepe M., Roux E.R., Lyman S.D., Shortman K., and McKenna H.J. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified. J. Exp. Med. 184 (1996) 1953-1962
18. Menges M., Baumeister T., Rößner S., Stoitzner P., Romani N., Gessner A., and Lutz M.B. IL-4 supports the generation of a dendritic cell subset from murine bone marrow with altered endocytosis capacity. J. Leukoc. Biol. 77 (2005) 535-543
19. Muller G., Muller A., Jonuleit H., Steinbrink K., Szalma C., Paragnik L., Lingnau K., Schmidt E., Knop J., and Enk A.H. Fetal calf serum-free generation of functionally active murine dendritic cells suitable for in vivo therapeutic approaches. J. Invest. Dermatol. 114 (2000) 142-149
20. Nikolic T., Bunk M., Drexhage H.A., and Leenen P.J. Bone marrow precursors of nonobese diabetic mice develop into defective macrophage-like dendritic cells in vitro. J. Immunol. 173 (2004) 4342-4351
21. Petersen M., Toldbod H., Holtz S., Hokland M., Bolund L., and Agger R. Strain-specific variations in the development of dendritic cells in murine bone-marrow cultures. Scand. J. Immunol. 51 (2000) 586-594
22. Prasad S.J., and Goodnow C.C. Intrinsic in vitro abnormalities in dendritic cell generation caused by non-MHC non-obese diabetic genes. Immunol. Cell Biol. 80 (2002) 198-206
23. Schreurs M.W., Eggert A.A., de Boer A.J., Figdor C.G., and Adema G.J. Generation and functional characterization of mouse monocyte-derived dendritic cells. Eur. J. Immunol. 29 (1999) 2835-2841
24. Shaw S.G., Maung A.A., Steptoe R.J., Thomson A.W., and Vujanovic N.L. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy. J. Immunol. 161 (1998) 2817-2824
25. Staquet M.J., Jacquet C., Dezutter-Dambuyant C., and Schmitt D. Fibronectin upregulates in vitro generation of dendritic Langerhans cells from human cord blood CD34+ progenitors. J. Invest. Dermatol. 109 (1997) 738-743
26. Steinman R.M., and Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137 (1973) 1142-1162
27. Steinman R.M., and Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J. Exp. Med. 139 (1974) 380-397
28. Steinman R.M., Lustig D.S., and Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. III. Functional properties in vivo. J. Exp. Med. 139 (1974) 1431-1445
29. Steinman R.M., Adams J.C., and Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. IV. Identification and distribution in mouse spleen. J. Exp. Med. 141 (1975) 804-820
30. Steinman R.M., Kaplan G., Witmer M.D., and Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J. Exp. Med. 149 (1979) 1-16
31. Stober D., Schirmbeck R., and Reimann J. IL-12/IL-18-dependent IFN-gamma release by murine dendritic cells. J. Immunol. 167 (2001) 957-965
32. Strid J., Lopes L., Marcinkiewicz J., Petrovska L., Nowak B., Chain B.M., and Lund T. A defect in bone marrow derived dendritic cell maturation in the nonobesediabetic mouse. Clin. Exp. Immunol. 123 (2001) 375-381
33. Strobl H., Bello-Fernandez C., Riedl E., Pickl W.F., Majdic O., Lyman S.D., and Knapp W. flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 90 (1997) 1425-1434
34. Suri R.M., and Austyn J.M. Bacterial lipopolysaccharide contamination of commercial collagen preparations may mediate dendritic cell maturation in culture. J. Immunol. Methods 214 (1998) 149-163
35. Toldbod H.E., Agger R., Bolund L., and Hokland M. Potent influence of bovine serum proteins in experimental dendritic cell-based vaccination protocols. Scand. J. Immunol. 58 (2003) 43-50
36. Vremec D., Zorbas M., Scollay R., Saunders D.J., Ardavin C.F., Wu L., and Shortman K. The surface phenotype of dendritic cells purified from mouse thymus and spleen: investigation of the CD8 expression by a subpopulation of dendritic cells. J. Exp. Med. 176 (1992) 47-58
37. Vremec D., Lieschke G.J., Dunn A.R., Robb L., Metcalf D., and Shortman K. The influence of granulocyte/macrophage colony-stimulating factor on dendritic cell levels in mouse lymphoid organs. Eur. J. Immunol. 27 (1997) 40-44
38. Warncke M., Dodero A., Dierbach H., Follo M., and Veelken H. Murine dendritic cells generated under serum-free conditions have a mature phenotype and efficiently induce primary immune responses. J. Immunol. Methods 310 (2006) 1-11
39. Wells J.W., Darling D., Farzaneh F., and Galea-Lauri J. Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions. Scand. J. Immunol. 61 (2005) 251-259